IspecimenISPC
13F holders, Q1 2025 (March 31)8holders +1
1new positions
0sold out
$1.06avg. 13F price*
At the end of Q1 2025, 8 institutions reported holding Ispecimen Inc. (ISPC) in their 13F filings, up 1 from Q4 2024. 1 opened new positions and 0 sold out. The largest holders were Bridgeway Capital Management, LLC ($23K), UBS Group AG ($23K) and Geode Capital Management, LLC ($11K).
- Company
- Ispecimen Inc.
- CUSIP
- 45032V207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $11K |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 24,321 shares bought, net +24,321 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Bridgeway Capital Management, LLC | 0.00% | No change | 21,800 | $23K |
| UBS Group AG | 0.00% | Add +97.8% | 21,711 | $23K |
| Geode Capital Management, LLC | 0.00% | New | 10,734 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +2175.6% | 2,981 | $3K |
| BlackRock, Inc. | 0.00% | No change | 2,827 | $3K |
| Bank of America Corp. | 0.00% | No change | 7 | $7 |
| Sachetta, LLC | 0.00% | No change | 2 | $3 |
| SBI Securities Co., Ltd. | 0.00% | No change | 2 | $2 |
"% of holder's portfolio" is ISPC's weight in each manager's 13F, not the share of Ispecimen Inc. the manager owns.